Tinabinol (INN; SP-119) is a synthetic cannabinoid drug and analogue of dronabinol and dimethylheptylpyran which was patented as an antihypertensive but was never marketed.[1][2]
This cannabinoid related article is a stub. You can help Wikipedia by expanding it.